Geneos Wealth Management’s Deciphera Pharmaceuticals, Inc. Common Stock DCPH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | – | Sell |
-1,000
| Closed | -$9K | – | 3026 |
|
|
2021
Q4 | $9K | Sell |
1,000
-1,050
| -51% | -$9.45K | ﹤0.01% | 2243 |
|
|
2021
Q3 | $70K | Sell |
2,050
-100
| -5% | -$3.42K | ﹤0.01% | 1333 |
|
|
2021
Q2 | $78K | Buy |
2,150
+500
| +30% | +$18.1K | ﹤0.01% | 1269 |
|
|
2021
Q1 | $76K | Hold |
1,650
| – | – | ﹤0.01% | 1419 |
|
|
2020
Q4 | $72K | Buy |
1,650
+400
| +32% | +$17.5K | ﹤0.01% | 1279 |
|
|
2020
Q3 | $62K | Sell |
1,250
-100
| -7% | -$4.96K | ﹤0.01% | 1159 |
|
|
2020
Q2 | $77K | Buy |
1,350
+200
| +17% | +$11.4K | ﹤0.01% | 1032 |
|
|
2020
Q1 | $48K | Buy |
1,150
+200
| +21% | +$8.35K | ﹤0.01% | 1131 |
|
|
2019
Q4 | $61K | Buy |
950
+150
| +19% | +$9.63K | ﹤0.01% | 1158 |
|
|
2019
Q3 | $26K | Sell |
800
-1,140
| -59% | -$37.1K | ﹤0.01% | 1495 |
|
|
2019
Q2 | $43K | Buy |
1,940
+550
| +40% | +$12.2K | ﹤0.01% | 1277 |
|
|
2019
Q1 | $32K | Buy |
1,390
+250
| +22% | +$5.76K | ﹤0.01% | 1366 |
|
|
2018
Q4 | $23K | Buy |
1,140
+470
| +70% | +$9.48K | ﹤0.01% | 1449 |
|
|
2018
Q3 | $25K | Buy |
+670
| New | +$25K | ﹤0.01% | 1489 |
|
|
2018
Q1 | – | Sell |
-300
| Closed | -$6K | – | 2249 |
|
|
2017
Q4 | $6K | Buy |
+300
| New | +$6K | ﹤0.01% | 1791 |
|